COVID-19 Impact on Global Insulin Drug Delivery Devices Market Insights, Forecast to 2026
Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Insulin Drug Delivery Devices market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Insulin Drug Delivery Devices industry.
Based on our recent survey, we have several different scenarios about the Insulin Drug Delivery Devices YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Insulin Drug Delivery Devices will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Insulin Drug Delivery Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Insulin Drug Delivery Devices market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Insulin Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Production and Pricing Analyses
Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Insulin Drug Delivery Devices market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Insulin Drug Delivery Devices market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Insulin Drug Delivery Devices market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Insulin Drug Delivery Devices market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Insulin Drug Delivery Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Insulin Drug Delivery Devices market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Insulin Drug Delivery Devices market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Insulin Drug Delivery Devices industry.
Based on our recent survey, we have several different scenarios about the Insulin Drug Delivery Devices YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Insulin Drug Delivery Devices will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Insulin Drug Delivery Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Insulin Drug Delivery Devices market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Insulin Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Production and Pricing Analyses
Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Insulin Drug Delivery Devices market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Insulin Drug Delivery Devices market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Insulin Drug Delivery Devices market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Insulin Drug Delivery Devices market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Insulin Drug Delivery Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Insulin Drug Delivery Devices market.
The following manufacturers are covered in this report:
- Novo Nordisk
- Sanofi
- BD
- Eli Lilly
- Medtronic
- Beta Bionics
- Dance Biopharm
- Roche
- Tandem Diabetes Care
- Animas
- Syringes
- Insulin Pens
- Jet Injectors
- Insulin Pumps
- Hospitals
- Clinics
- Homecare
- Others
1 STUDY COVERAGE
1.1 Insulin Drug Delivery Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Insulin Drug Delivery Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Insulin Drug Delivery Devices Market Size Growth Rate by Type
1.4.2 Syringes
1.4.3 Insulin Pens
1.4.4 Jet Injectors
1.4.5 Insulin Pumps
1.5 Market by Application
1.5.1 Global Insulin Drug Delivery Devices Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Homecare
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Insulin Drug Delivery Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the Insulin Drug Delivery Devices Industry
1.6.1.1 Insulin Drug Delivery Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Insulin Drug Delivery Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Insulin Drug Delivery Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Insulin Drug Delivery Devices Market Size Estimates and Forecasts
2.1.1 Global Insulin Drug Delivery Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Insulin Drug Delivery Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Insulin Drug Delivery Devices Production Estimates and Forecasts 2015-2026
2.2 Global Insulin Drug Delivery Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Insulin Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Insulin Drug Delivery Devices Manufacturers Geographical Distribution
2.4 Key Trends for Insulin Drug Delivery Devices Markets & Products
2.5 Primary Interviews with Key Insulin Drug Delivery Devices Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Insulin Drug Delivery Devices Manufacturers by Production Capacity
3.1.1 Global Top Insulin Drug Delivery Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Insulin Drug Delivery Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Insulin Drug Delivery Devices Manufacturers Market Share by Production
3.2 Global Top Insulin Drug Delivery Devices Manufacturers by Revenue
3.2.1 Global Top Insulin Drug Delivery Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Insulin Drug Delivery Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Drug Delivery Devices Revenue in 2019
3.3 Global Insulin Drug Delivery Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 INSULIN DRUG DELIVERY DEVICES PRODUCTION BY REGIONS
4.1 Global Insulin Drug Delivery Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Insulin Drug Delivery Devices Regions by Production (2015-2020)
4.1.2 Global Top Insulin Drug Delivery Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Insulin Drug Delivery Devices Production (2015-2020)
4.2.2 North America Insulin Drug Delivery Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Insulin Drug Delivery Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Insulin Drug Delivery Devices Production (2015-2020)
4.3.2 Europe Insulin Drug Delivery Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Insulin Drug Delivery Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Insulin Drug Delivery Devices Production (2015-2020)
4.4.2 China Insulin Drug Delivery Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Insulin Drug Delivery Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Insulin Drug Delivery Devices Production (2015-2020)
4.5.2 Japan Insulin Drug Delivery Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Insulin Drug Delivery Devices Import & Export (2015-2020)
5 INSULIN DRUG DELIVERY DEVICES CONSUMPTION BY REGION
5.1 Global Top Insulin Drug Delivery Devices Regions by Consumption
5.1.1 Global Top Insulin Drug Delivery Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Insulin Drug Delivery Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Insulin Drug Delivery Devices Consumption by Application
5.2.2 North America Insulin Drug Delivery Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Insulin Drug Delivery Devices Consumption by Application
5.3.2 Europe Insulin Drug Delivery Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Insulin Drug Delivery Devices Consumption by Application
5.4.2 Asia Pacific Insulin Drug Delivery Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Insulin Drug Delivery Devices Consumption by Application
5.5.2 Central & South America Insulin Drug Delivery Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Insulin Drug Delivery Devices Consumption by Application
5.6.2 Middle East and Africa Insulin Drug Delivery Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Insulin Drug Delivery Devices Market Size by Type (2015-2020)
6.1.1 Global Insulin Drug Delivery Devices Production by Type (2015-2020)
6.1.2 Global Insulin Drug Delivery Devices Revenue by Type (2015-2020)
6.1.3 Insulin Drug Delivery Devices Price by Type (2015-2020)
6.2 Global Insulin Drug Delivery Devices Market Forecast by Type (2021-2026)
6.2.1 Global Insulin Drug Delivery Devices Production Forecast by Type (2021-2026)
6.2.2 Global Insulin Drug Delivery Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Insulin Drug Delivery Devices Price Forecast by Type (2021-2026)
6.3 Global Insulin Drug Delivery Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Insulin Drug Delivery Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Insulin Drug Delivery Devices Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Novo Nordisk
8.1.1 Novo Nordisk Corporation Information
8.1.2 Novo Nordisk Overview and Its Total Revenue
8.1.3 Novo Nordisk Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Novo Nordisk Product Description
8.1.5 Novo Nordisk Recent Development
8.2 Sanofi
8.2.1 Sanofi Corporation Information
8.2.2 Sanofi Overview and Its Total Revenue
8.2.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Sanofi Product Description
8.2.5 Sanofi Recent Development
8.3 BD
8.3.1 BD Corporation Information
8.3.2 BD Overview and Its Total Revenue
8.3.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 BD Product Description
8.3.5 BD Recent Development
8.4 Eli Lilly
8.4.1 Eli Lilly Corporation Information
8.4.2 Eli Lilly Overview and Its Total Revenue
8.4.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Eli Lilly Product Description
8.4.5 Eli Lilly Recent Development
8.5 Medtronic
8.5.1 Medtronic Corporation Information
8.5.2 Medtronic Overview and Its Total Revenue
8.5.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Medtronic Product Description
8.5.5 Medtronic Recent Development
8.6 Beta Bionics
8.6.1 Beta Bionics Corporation Information
8.6.2 Beta Bionics Overview and Its Total Revenue
8.6.3 Beta Bionics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Beta Bionics Product Description
8.6.5 Beta Bionics Recent Development
8.7 Dance Biopharm
8.7.1 Dance Biopharm Corporation Information
8.7.2 Dance Biopharm Overview and Its Total Revenue
8.7.3 Dance Biopharm Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Dance Biopharm Product Description
8.7.5 Dance Biopharm Recent Development
8.8 Roche
8.8.1 Roche Corporation Information
8.8.2 Roche Overview and Its Total Revenue
8.8.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Roche Product Description
8.8.5 Roche Recent Development
8.9 Tandem Diabetes Care
8.9.1 Tandem Diabetes Care Corporation Information
8.9.2 Tandem Diabetes Care Overview and Its Total Revenue
8.9.3 Tandem Diabetes Care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Tandem Diabetes Care Product Description
8.9.5 Tandem Diabetes Care Recent Development
8.10 Animas
8.10.1 Animas Corporation Information
8.10.2 Animas Overview and Its Total Revenue
8.10.3 Animas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Animas Product Description
8.10.5 Animas Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Insulin Drug Delivery Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Insulin Drug Delivery Devices Regions Forecast by Production (2021-2026)
9.3 Key Insulin Drug Delivery Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 INSULIN DRUG DELIVERY DEVICES CONSUMPTION FORECAST BY REGION
10.1 Global Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.2 North America Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Insulin Drug Delivery Devices Sales Channels
11.2.2 Insulin Drug Delivery Devices Distributors
11.3 Insulin Drug Delivery Devices Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL INSULIN DRUG DELIVERY DEVICES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Insulin Drug Delivery Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Insulin Drug Delivery Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Insulin Drug Delivery Devices Market Size Growth Rate by Type
1.4.2 Syringes
1.4.3 Insulin Pens
1.4.4 Jet Injectors
1.4.5 Insulin Pumps
1.5 Market by Application
1.5.1 Global Insulin Drug Delivery Devices Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Homecare
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Insulin Drug Delivery Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the Insulin Drug Delivery Devices Industry
1.6.1.1 Insulin Drug Delivery Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Insulin Drug Delivery Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Insulin Drug Delivery Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Insulin Drug Delivery Devices Market Size Estimates and Forecasts
2.1.1 Global Insulin Drug Delivery Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Insulin Drug Delivery Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Insulin Drug Delivery Devices Production Estimates and Forecasts 2015-2026
2.2 Global Insulin Drug Delivery Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Insulin Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Insulin Drug Delivery Devices Manufacturers Geographical Distribution
2.4 Key Trends for Insulin Drug Delivery Devices Markets & Products
2.5 Primary Interviews with Key Insulin Drug Delivery Devices Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Insulin Drug Delivery Devices Manufacturers by Production Capacity
3.1.1 Global Top Insulin Drug Delivery Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Insulin Drug Delivery Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Insulin Drug Delivery Devices Manufacturers Market Share by Production
3.2 Global Top Insulin Drug Delivery Devices Manufacturers by Revenue
3.2.1 Global Top Insulin Drug Delivery Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Insulin Drug Delivery Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Drug Delivery Devices Revenue in 2019
3.3 Global Insulin Drug Delivery Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 INSULIN DRUG DELIVERY DEVICES PRODUCTION BY REGIONS
4.1 Global Insulin Drug Delivery Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Insulin Drug Delivery Devices Regions by Production (2015-2020)
4.1.2 Global Top Insulin Drug Delivery Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Insulin Drug Delivery Devices Production (2015-2020)
4.2.2 North America Insulin Drug Delivery Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Insulin Drug Delivery Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Insulin Drug Delivery Devices Production (2015-2020)
4.3.2 Europe Insulin Drug Delivery Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Insulin Drug Delivery Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Insulin Drug Delivery Devices Production (2015-2020)
4.4.2 China Insulin Drug Delivery Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Insulin Drug Delivery Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Insulin Drug Delivery Devices Production (2015-2020)
4.5.2 Japan Insulin Drug Delivery Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Insulin Drug Delivery Devices Import & Export (2015-2020)
5 INSULIN DRUG DELIVERY DEVICES CONSUMPTION BY REGION
5.1 Global Top Insulin Drug Delivery Devices Regions by Consumption
5.1.1 Global Top Insulin Drug Delivery Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Insulin Drug Delivery Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Insulin Drug Delivery Devices Consumption by Application
5.2.2 North America Insulin Drug Delivery Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Insulin Drug Delivery Devices Consumption by Application
5.3.2 Europe Insulin Drug Delivery Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Insulin Drug Delivery Devices Consumption by Application
5.4.2 Asia Pacific Insulin Drug Delivery Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Insulin Drug Delivery Devices Consumption by Application
5.5.2 Central & South America Insulin Drug Delivery Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Insulin Drug Delivery Devices Consumption by Application
5.6.2 Middle East and Africa Insulin Drug Delivery Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Insulin Drug Delivery Devices Market Size by Type (2015-2020)
6.1.1 Global Insulin Drug Delivery Devices Production by Type (2015-2020)
6.1.2 Global Insulin Drug Delivery Devices Revenue by Type (2015-2020)
6.1.3 Insulin Drug Delivery Devices Price by Type (2015-2020)
6.2 Global Insulin Drug Delivery Devices Market Forecast by Type (2021-2026)
6.2.1 Global Insulin Drug Delivery Devices Production Forecast by Type (2021-2026)
6.2.2 Global Insulin Drug Delivery Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Insulin Drug Delivery Devices Price Forecast by Type (2021-2026)
6.3 Global Insulin Drug Delivery Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Insulin Drug Delivery Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Insulin Drug Delivery Devices Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Novo Nordisk
8.1.1 Novo Nordisk Corporation Information
8.1.2 Novo Nordisk Overview and Its Total Revenue
8.1.3 Novo Nordisk Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Novo Nordisk Product Description
8.1.5 Novo Nordisk Recent Development
8.2 Sanofi
8.2.1 Sanofi Corporation Information
8.2.2 Sanofi Overview and Its Total Revenue
8.2.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Sanofi Product Description
8.2.5 Sanofi Recent Development
8.3 BD
8.3.1 BD Corporation Information
8.3.2 BD Overview and Its Total Revenue
8.3.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 BD Product Description
8.3.5 BD Recent Development
8.4 Eli Lilly
8.4.1 Eli Lilly Corporation Information
8.4.2 Eli Lilly Overview and Its Total Revenue
8.4.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Eli Lilly Product Description
8.4.5 Eli Lilly Recent Development
8.5 Medtronic
8.5.1 Medtronic Corporation Information
8.5.2 Medtronic Overview and Its Total Revenue
8.5.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Medtronic Product Description
8.5.5 Medtronic Recent Development
8.6 Beta Bionics
8.6.1 Beta Bionics Corporation Information
8.6.2 Beta Bionics Overview and Its Total Revenue
8.6.3 Beta Bionics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Beta Bionics Product Description
8.6.5 Beta Bionics Recent Development
8.7 Dance Biopharm
8.7.1 Dance Biopharm Corporation Information
8.7.2 Dance Biopharm Overview and Its Total Revenue
8.7.3 Dance Biopharm Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Dance Biopharm Product Description
8.7.5 Dance Biopharm Recent Development
8.8 Roche
8.8.1 Roche Corporation Information
8.8.2 Roche Overview and Its Total Revenue
8.8.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Roche Product Description
8.8.5 Roche Recent Development
8.9 Tandem Diabetes Care
8.9.1 Tandem Diabetes Care Corporation Information
8.9.2 Tandem Diabetes Care Overview and Its Total Revenue
8.9.3 Tandem Diabetes Care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Tandem Diabetes Care Product Description
8.9.5 Tandem Diabetes Care Recent Development
8.10 Animas
8.10.1 Animas Corporation Information
8.10.2 Animas Overview and Its Total Revenue
8.10.3 Animas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Animas Product Description
8.10.5 Animas Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Insulin Drug Delivery Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Insulin Drug Delivery Devices Regions Forecast by Production (2021-2026)
9.3 Key Insulin Drug Delivery Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 INSULIN DRUG DELIVERY DEVICES CONSUMPTION FORECAST BY REGION
10.1 Global Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.2 North America Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Insulin Drug Delivery Devices Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Insulin Drug Delivery Devices Sales Channels
11.2.2 Insulin Drug Delivery Devices Distributors
11.3 Insulin Drug Delivery Devices Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL INSULIN DRUG DELIVERY DEVICES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Insulin Drug Delivery Devices Key Market Segments in This Study
Table 2. Ranking of Global Top Insulin Drug Delivery Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Drug Delivery Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Syringes
Table 5. Major Manufacturers of Insulin Pens
Table 6. Major Manufacturers of Jet Injectors
Table 7. Major Manufacturers of Insulin Pumps
Table 8. COVID-19 Impact Global Market: (Four Insulin Drug Delivery Devices Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Insulin Drug Delivery Devices Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Insulin Drug Delivery Devices Players to Combat Covid-19 Impact
Table 13. Global Insulin Drug Delivery Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Insulin Drug Delivery Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Insulin Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Drug Delivery Devices as of 2019)
Table 17. Insulin Drug Delivery Devices Manufacturing Base Distribution and Headquarters
Table 18. Manufacturers Insulin Drug Delivery Devices Product Offered
Table 19. Date of Manufacturers Enter into Insulin Drug Delivery Devices Market
Table 20. Key Trends for Insulin Drug Delivery Devices Markets & Products
Table 21. Main Points Interviewed from Key Insulin Drug Delivery Devices Players
Table 22. Global Insulin Drug Delivery Devices Production Capacity by Manufacturers (2015-2020) (K Units)
Table 23. Global Insulin Drug Delivery Devices Production Share by Manufacturers (2015-2020)
Table 24. Insulin Drug Delivery Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 25. Insulin Drug Delivery Devices Revenue Share by Manufacturers (2015-2020)
Table 26. Insulin Drug Delivery Devices Price by Manufacturers 2015-2020 (USD/Unit)
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Insulin Drug Delivery Devices Production by Regions (2015-2020) (K Units)
Table 29. Global Insulin Drug Delivery Devices Production Market Share by Regions (2015-2020)
Table 30. Global Insulin Drug Delivery Devices Revenue by Regions (2015-2020) (US$ Million)
Table 31. Global Insulin Drug Delivery Devices Revenue Market Share by Regions (2015-2020)
Table 32. Key Insulin Drug Delivery Devices Players in North America
Table 33. Import & Export of Insulin Drug Delivery Devices in North America (K Units)
Table 34. Key Insulin Drug Delivery Devices Players in Europe
Table 35. Import & Export of Insulin Drug Delivery Devices in Europe (K Units)
Table 36. Key Insulin Drug Delivery Devices Players in China
Table 37. Import & Export of Insulin Drug Delivery Devices in China (K Units)
Table 38. Key Insulin Drug Delivery Devices Players in Japan
Table 39. Import & Export of Insulin Drug Delivery Devices in Japan (K Units)
Table 40. Global Insulin Drug Delivery Devices Consumption by Regions (2015-2020) (K Units)
Table 41. Global Insulin Drug Delivery Devices Consumption Market Share by Regions (2015-2020)
Table 42. North America Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 43. North America Insulin Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 44. Europe Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 45. Europe Insulin Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 46. Asia Pacific Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 47. Asia Pacific Insulin Drug Delivery Devices Consumption Market Share by Application (2015-2020) (K Units)
Table 48. Asia Pacific Insulin Drug Delivery Devices Consumption by Regions (2015-2020) (K Units)
Table 49. Latin America Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 50. Latin America Insulin Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 51. Middle East and Africa Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 52. Middle East and Africa Insulin Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 53. Global Insulin Drug Delivery Devices Production by Type (2015-2020) (K Units)
Table 54. Global Insulin Drug Delivery Devices Production Share by Type (2015-2020)
Table 55. Global Insulin Drug Delivery Devices Revenue by Type (2015-2020) (Million US$)
Table 56. Global Insulin Drug Delivery Devices Revenue Share by Type (2015-2020)
Table 57. Insulin Drug Delivery Devices Price by Type 2015-2020 (USD/Unit)
Table 58. Global Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 59. Global Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 60. Global Insulin Drug Delivery Devices Consumption Share by Application (2015-2020)
Table 61. Novo Nordisk Corporation Information
Table 62. Novo Nordisk Description and Major Businesses
Table 63. Novo Nordisk Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 64. Novo Nordisk Product
Table 65. Novo Nordisk Recent Development
Table 66. Sanofi Corporation Information
Table 67. Sanofi Description and Major Businesses
Table 68. Sanofi Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. Sanofi Product
Table 70. Sanofi Recent Development
Table 71. BD Corporation Information
Table 72. BD Description and Major Businesses
Table 73. BD Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. BD Product
Table 75. BD Recent Development
Table 76. Eli Lilly Corporation Information
Table 77. Eli Lilly Description and Major Businesses
Table 78. Eli Lilly Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Eli Lilly Product
Table 80. Eli Lilly Recent Development
Table 81. Medtronic Corporation Information
Table 82. Medtronic Description and Major Businesses
Table 83. Medtronic Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Medtronic Product
Table 85. Medtronic Recent Development
Table 86. Beta Bionics Corporation Information
Table 87. Beta Bionics Description and Major Businesses
Table 88. Beta Bionics Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Beta Bionics Product
Table 90. Beta Bionics Recent Development
Table 91. Dance Biopharm Corporation Information
Table 92. Dance Biopharm Description and Major Businesses
Table 93. Dance Biopharm Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Dance Biopharm Product
Table 95. Dance Biopharm Recent Development
Table 96. Roche Corporation Information
Table 97. Roche Description and Major Businesses
Table 98. Roche Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Roche Product
Table 100. Roche Recent Development
Table 101. Tandem Diabetes Care Corporation Information
Table 102. Tandem Diabetes Care Description and Major Businesses
Table 103. Tandem Diabetes Care Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Tandem Diabetes Care Product
Table 105. Tandem Diabetes Care Recent Development
Table 106. Animas Corporation Information
Table 107. Animas Description and Major Businesses
Table 108. Animas Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Animas Product
Table 110. Animas Recent Development
Table 111. Global Insulin Drug Delivery Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 112. Global Insulin Drug Delivery Devices Production Forecast by Regions (2021-2026) (K Units)
Table 113. Global Insulin Drug Delivery Devices Production Forecast by Type (2021-2026) (K Units)
Table 114. Global Insulin Drug Delivery Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 115. North America Insulin Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 116. Europe Insulin Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 117. Asia Pacific Insulin Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 118. Latin America Insulin Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 119. Middle East and Africa Insulin Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 120. Insulin Drug Delivery Devices Distributors List
Table 121. Insulin Drug Delivery Devices Customers List
Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 123. Key Challenges
Table 124. Market Risks
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 1. Insulin Drug Delivery Devices Key Market Segments in This Study
Table 2. Ranking of Global Top Insulin Drug Delivery Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Drug Delivery Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Syringes
Table 5. Major Manufacturers of Insulin Pens
Table 6. Major Manufacturers of Jet Injectors
Table 7. Major Manufacturers of Insulin Pumps
Table 8. COVID-19 Impact Global Market: (Four Insulin Drug Delivery Devices Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Insulin Drug Delivery Devices Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Insulin Drug Delivery Devices Players to Combat Covid-19 Impact
Table 13. Global Insulin Drug Delivery Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Insulin Drug Delivery Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Insulin Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Drug Delivery Devices as of 2019)
Table 17. Insulin Drug Delivery Devices Manufacturing Base Distribution and Headquarters
Table 18. Manufacturers Insulin Drug Delivery Devices Product Offered
Table 19. Date of Manufacturers Enter into Insulin Drug Delivery Devices Market
Table 20. Key Trends for Insulin Drug Delivery Devices Markets & Products
Table 21. Main Points Interviewed from Key Insulin Drug Delivery Devices Players
Table 22. Global Insulin Drug Delivery Devices Production Capacity by Manufacturers (2015-2020) (K Units)
Table 23. Global Insulin Drug Delivery Devices Production Share by Manufacturers (2015-2020)
Table 24. Insulin Drug Delivery Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 25. Insulin Drug Delivery Devices Revenue Share by Manufacturers (2015-2020)
Table 26. Insulin Drug Delivery Devices Price by Manufacturers 2015-2020 (USD/Unit)
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Insulin Drug Delivery Devices Production by Regions (2015-2020) (K Units)
Table 29. Global Insulin Drug Delivery Devices Production Market Share by Regions (2015-2020)
Table 30. Global Insulin Drug Delivery Devices Revenue by Regions (2015-2020) (US$ Million)
Table 31. Global Insulin Drug Delivery Devices Revenue Market Share by Regions (2015-2020)
Table 32. Key Insulin Drug Delivery Devices Players in North America
Table 33. Import & Export of Insulin Drug Delivery Devices in North America (K Units)
Table 34. Key Insulin Drug Delivery Devices Players in Europe
Table 35. Import & Export of Insulin Drug Delivery Devices in Europe (K Units)
Table 36. Key Insulin Drug Delivery Devices Players in China
Table 37. Import & Export of Insulin Drug Delivery Devices in China (K Units)
Table 38. Key Insulin Drug Delivery Devices Players in Japan
Table 39. Import & Export of Insulin Drug Delivery Devices in Japan (K Units)
Table 40. Global Insulin Drug Delivery Devices Consumption by Regions (2015-2020) (K Units)
Table 41. Global Insulin Drug Delivery Devices Consumption Market Share by Regions (2015-2020)
Table 42. North America Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 43. North America Insulin Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 44. Europe Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 45. Europe Insulin Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 46. Asia Pacific Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 47. Asia Pacific Insulin Drug Delivery Devices Consumption Market Share by Application (2015-2020) (K Units)
Table 48. Asia Pacific Insulin Drug Delivery Devices Consumption by Regions (2015-2020) (K Units)
Table 49. Latin America Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 50. Latin America Insulin Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 51. Middle East and Africa Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 52. Middle East and Africa Insulin Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 53. Global Insulin Drug Delivery Devices Production by Type (2015-2020) (K Units)
Table 54. Global Insulin Drug Delivery Devices Production Share by Type (2015-2020)
Table 55. Global Insulin Drug Delivery Devices Revenue by Type (2015-2020) (Million US$)
Table 56. Global Insulin Drug Delivery Devices Revenue Share by Type (2015-2020)
Table 57. Insulin Drug Delivery Devices Price by Type 2015-2020 (USD/Unit)
Table 58. Global Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 59. Global Insulin Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 60. Global Insulin Drug Delivery Devices Consumption Share by Application (2015-2020)
Table 61. Novo Nordisk Corporation Information
Table 62. Novo Nordisk Description and Major Businesses
Table 63. Novo Nordisk Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 64. Novo Nordisk Product
Table 65. Novo Nordisk Recent Development
Table 66. Sanofi Corporation Information
Table 67. Sanofi Description and Major Businesses
Table 68. Sanofi Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. Sanofi Product
Table 70. Sanofi Recent Development
Table 71. BD Corporation Information
Table 72. BD Description and Major Businesses
Table 73. BD Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. BD Product
Table 75. BD Recent Development
Table 76. Eli Lilly Corporation Information
Table 77. Eli Lilly Description and Major Businesses
Table 78. Eli Lilly Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Eli Lilly Product
Table 80. Eli Lilly Recent Development
Table 81. Medtronic Corporation Information
Table 82. Medtronic Description and Major Businesses
Table 83. Medtronic Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Medtronic Product
Table 85. Medtronic Recent Development
Table 86. Beta Bionics Corporation Information
Table 87. Beta Bionics Description and Major Businesses
Table 88. Beta Bionics Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Beta Bionics Product
Table 90. Beta Bionics Recent Development
Table 91. Dance Biopharm Corporation Information
Table 92. Dance Biopharm Description and Major Businesses
Table 93. Dance Biopharm Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Dance Biopharm Product
Table 95. Dance Biopharm Recent Development
Table 96. Roche Corporation Information
Table 97. Roche Description and Major Businesses
Table 98. Roche Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Roche Product
Table 100. Roche Recent Development
Table 101. Tandem Diabetes Care Corporation Information
Table 102. Tandem Diabetes Care Description and Major Businesses
Table 103. Tandem Diabetes Care Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Tandem Diabetes Care Product
Table 105. Tandem Diabetes Care Recent Development
Table 106. Animas Corporation Information
Table 107. Animas Description and Major Businesses
Table 108. Animas Insulin Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Animas Product
Table 110. Animas Recent Development
Table 111. Global Insulin Drug Delivery Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 112. Global Insulin Drug Delivery Devices Production Forecast by Regions (2021-2026) (K Units)
Table 113. Global Insulin Drug Delivery Devices Production Forecast by Type (2021-2026) (K Units)
Table 114. Global Insulin Drug Delivery Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 115. North America Insulin Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 116. Europe Insulin Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 117. Asia Pacific Insulin Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 118. Latin America Insulin Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 119. Middle East and Africa Insulin Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 120. Insulin Drug Delivery Devices Distributors List
Table 121. Insulin Drug Delivery Devices Customers List
Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 123. Key Challenges
Table 124. Market Risks
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Insulin Drug Delivery Devices Product Picture
Figure 2. Global Insulin Drug Delivery Devices Production Market Share by Type in 2020 & 2026
Figure 3. Syringes Product Picture
Figure 4. Insulin Pens Product Picture
Figure 5. Jet Injectors Product Picture
Figure 6. Insulin Pumps Product Picture
Figure 7. Global Insulin Drug Delivery Devices Consumption Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Homecare
Figure 11. Others
Figure 12. Insulin Drug Delivery Devices Report Years Considered
Figure 13. Global Insulin Drug Delivery Devices Revenue 2015-2026 (Million US$)
Figure 14. Global Insulin Drug Delivery Devices Production Capacity 2015-2026 (K Units)
Figure 15. Global Insulin Drug Delivery Devices Production 2015-2026 (K Units)
Figure 16. Global Insulin Drug Delivery Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 17. Insulin Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Insulin Drug Delivery Devices Production Share by Manufacturers in 2015
Figure 19. The Top 10 and Top 5 Players Market Share by Insulin Drug Delivery Devices Revenue in 2019
Figure 20. Global Insulin Drug Delivery Devices Production Market Share by Region (2015-2020)
Figure 21. Insulin Drug Delivery Devices Production Growth Rate in North America (2015-2020) (K Units)
Figure 22. Insulin Drug Delivery Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 23. Insulin Drug Delivery Devices Production Growth Rate in Europe (2015-2020) (K Units)
Figure 24. Insulin Drug Delivery Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 25. Insulin Drug Delivery Devices Production Growth Rate in China (2015-2020) (K Units)
Figure 26. Insulin Drug Delivery Devices Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 27. Insulin Drug Delivery Devices Production Growth Rate in Japan (2015-2020) (K Units)
Figure 28. Insulin Drug Delivery Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 29. Global Insulin Drug Delivery Devices Consumption Market Share by Regions 2015-2020
Figure 30. North America Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. North America Insulin Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 32. North America Insulin Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 33. U.S. Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Canada Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Europe Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Europe Insulin Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 37. Europe Insulin Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 38. Germany Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. France Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. U.K. Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Italy Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Russia Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Asia Pacific Insulin Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 44. Asia Pacific Insulin Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 45. Asia Pacific Insulin Drug Delivery Devices Consumption Market Share by Regions in 2019
Figure 46. China Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Japan Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. India Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Australia Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Thailand Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Malaysia Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Philippines Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Vietnam Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Latin America Insulin Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 58. Latin America Insulin Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 59. Latin America Insulin Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 60. Mexico Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Brazil Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Argentina Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Middle East and Africa Insulin Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 64. Middle East and Africa Insulin Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 65. Middle East and Africa Insulin Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 66. Turkey Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Saudi Arabia Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. U.A.E Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. Global Insulin Drug Delivery Devices Production Market Share by Type (2015-2020)
Figure 70. Global Insulin Drug Delivery Devices Production Market Share by Type in 2019
Figure 71. Global Insulin Drug Delivery Devices Revenue Market Share by Type (2015-2020)
Figure 72. Global Insulin Drug Delivery Devices Revenue Market Share by Type in 2019
Figure 73. Global Insulin Drug Delivery Devices Production Market Share Forecast by Type (2021-2026)
Figure 74. Global Insulin Drug Delivery Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 75. Global Insulin Drug Delivery Devices Market Share by Price Range (2015-2020)
Figure 76. Global Insulin Drug Delivery Devices Consumption Market Share by Application (2015-2020)
Figure 77. Global Insulin Drug Delivery Devices Value (Consumption) Market Share by Application (2015-2020)
Figure 78. Global Insulin Drug Delivery Devices Consumption Market Share Forecast by Application (2021-2026)
Figure 79. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Beta Bionics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Dance Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Tandem Diabetes Care Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Animas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Global Insulin Drug Delivery Devices Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 90. Global Insulin Drug Delivery Devices Revenue Market Share Forecast by Regions ((2021-2026))
Figure 91. Global Insulin Drug Delivery Devices Production Forecast by Regions (2021-2026) (K Units)
Figure 92. North America Insulin Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 93. North America Insulin Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 94. Europe Insulin Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 95. Europe Insulin Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 96. China Insulin Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 97. China Insulin Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 98. Japan Insulin Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 99. Japan Insulin Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 100. Global Insulin Drug Delivery Devices Consumption Market Share Forecast by Region (2021-2026)
Figure 101. Insulin Drug Delivery Devices Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed
Figure 1. Insulin Drug Delivery Devices Product Picture
Figure 2. Global Insulin Drug Delivery Devices Production Market Share by Type in 2020 & 2026
Figure 3. Syringes Product Picture
Figure 4. Insulin Pens Product Picture
Figure 5. Jet Injectors Product Picture
Figure 6. Insulin Pumps Product Picture
Figure 7. Global Insulin Drug Delivery Devices Consumption Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Homecare
Figure 11. Others
Figure 12. Insulin Drug Delivery Devices Report Years Considered
Figure 13. Global Insulin Drug Delivery Devices Revenue 2015-2026 (Million US$)
Figure 14. Global Insulin Drug Delivery Devices Production Capacity 2015-2026 (K Units)
Figure 15. Global Insulin Drug Delivery Devices Production 2015-2026 (K Units)
Figure 16. Global Insulin Drug Delivery Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 17. Insulin Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Insulin Drug Delivery Devices Production Share by Manufacturers in 2015
Figure 19. The Top 10 and Top 5 Players Market Share by Insulin Drug Delivery Devices Revenue in 2019
Figure 20. Global Insulin Drug Delivery Devices Production Market Share by Region (2015-2020)
Figure 21. Insulin Drug Delivery Devices Production Growth Rate in North America (2015-2020) (K Units)
Figure 22. Insulin Drug Delivery Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 23. Insulin Drug Delivery Devices Production Growth Rate in Europe (2015-2020) (K Units)
Figure 24. Insulin Drug Delivery Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 25. Insulin Drug Delivery Devices Production Growth Rate in China (2015-2020) (K Units)
Figure 26. Insulin Drug Delivery Devices Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 27. Insulin Drug Delivery Devices Production Growth Rate in Japan (2015-2020) (K Units)
Figure 28. Insulin Drug Delivery Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 29. Global Insulin Drug Delivery Devices Consumption Market Share by Regions 2015-2020
Figure 30. North America Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. North America Insulin Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 32. North America Insulin Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 33. U.S. Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Canada Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Europe Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Europe Insulin Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 37. Europe Insulin Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 38. Germany Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. France Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. U.K. Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Italy Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Russia Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Asia Pacific Insulin Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 44. Asia Pacific Insulin Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 45. Asia Pacific Insulin Drug Delivery Devices Consumption Market Share by Regions in 2019
Figure 46. China Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Japan Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. India Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Australia Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Thailand Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Malaysia Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Philippines Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Vietnam Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Latin America Insulin Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 58. Latin America Insulin Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 59. Latin America Insulin Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 60. Mexico Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Brazil Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Argentina Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Middle East and Africa Insulin Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 64. Middle East and Africa Insulin Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 65. Middle East and Africa Insulin Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 66. Turkey Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Saudi Arabia Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. U.A.E Insulin Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. Global Insulin Drug Delivery Devices Production Market Share by Type (2015-2020)
Figure 70. Global Insulin Drug Delivery Devices Production Market Share by Type in 2019
Figure 71. Global Insulin Drug Delivery Devices Revenue Market Share by Type (2015-2020)
Figure 72. Global Insulin Drug Delivery Devices Revenue Market Share by Type in 2019
Figure 73. Global Insulin Drug Delivery Devices Production Market Share Forecast by Type (2021-2026)
Figure 74. Global Insulin Drug Delivery Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 75. Global Insulin Drug Delivery Devices Market Share by Price Range (2015-2020)
Figure 76. Global Insulin Drug Delivery Devices Consumption Market Share by Application (2015-2020)
Figure 77. Global Insulin Drug Delivery Devices Value (Consumption) Market Share by Application (2015-2020)
Figure 78. Global Insulin Drug Delivery Devices Consumption Market Share Forecast by Application (2021-2026)
Figure 79. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Beta Bionics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Dance Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Tandem Diabetes Care Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Animas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Global Insulin Drug Delivery Devices Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 90. Global Insulin Drug Delivery Devices Revenue Market Share Forecast by Regions ((2021-2026))
Figure 91. Global Insulin Drug Delivery Devices Production Forecast by Regions (2021-2026) (K Units)
Figure 92. North America Insulin Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 93. North America Insulin Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 94. Europe Insulin Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 95. Europe Insulin Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 96. China Insulin Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 97. China Insulin Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 98. Japan Insulin Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 99. Japan Insulin Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 100. Global Insulin Drug Delivery Devices Consumption Market Share Forecast by Region (2021-2026)
Figure 101. Insulin Drug Delivery Devices Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed
